Berkshire Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,026
Closed -$244K 159
2026
Q1
$244K Hold
4,026
0.05% 145
2025
Q4
$217K Sell
4,026
-5,409
-57% -$260K 0.04% 150
2025
Q3
$426K Sell
9,435
-210
-2% -$9.81K 0.09% 109
2025
Q2
$446K Sell
9,645
-306
-3% -$15K 0.1% 105
2025
Q1
$607K Sell
9,951
-284
-3% -$16.6K 0.15% 88
2024
Q4
$579K Sell
10,235
-829
-7% -$46.3K 0.13% 89
2024
Q3
$572K Sell
11,064
-1,862
-14% -$87.3K 0.13% 94
2024
Q2
$537K Sell
12,926
-2,310
-15% -$103K 0.13% 93
2024
Q1
$826K Sell
15,236
-9,322
-38% -$475K 0.21% 77
2023
Q4
$1.26M Sell
24,558
-1,916
-7% -$101K 0.33% 62
2023
Q3
$1.54M Sell
26,474
-9
-0% -$551 0.44% 49
2023
Q2
$1.69M Sell
26,483
-2,239
-8% -$150K 0.47% 51
2023
Q1
$1.99M Sell
28,722
-3,434
-11% -$242K 0.59% 40
2022
Q4
$2.31M Sell
32,156
-5,782
-15% -$436K 0.71% 38
2022
Q3
$2.7M Sell
37,938
-4,629
-11% -$336K 0.82% 36
2022
Q2
$3.28M Sell
42,567
-5,124
-11% -$390K 0.95% 30
2022
Q1
$3.48M Sell
47,691
-2,743
-5% -$184K 0.83% 35
2021
Q4
$3.14M Sell
50,434
-2,801
-5% -$164K 0.7% 38
2021
Q3
$3.15M Buy
53,235
+763
+1% +$50.2K 0.77% 38
2021
Q2
$3.51M Buy
52,472
+2,419
+5% +$158K 0.85% 34
2021
Q1
$3.16M Buy
50,053
+113
+0.2% +$7.03K 0.79% 35
2020
Q4
$3.1M Buy
49,940
+2,718
+6% +$167K 0.77% 33
2020
Q3
$2.85M Buy
+47,222
New +$2.84M 0.76% 35

Other funds holding BMY

Berkshire Bank's BMY Position: Q2 2026 in Review

Berkshire Bank sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 4,026 shares — an estimated $244K sold.

Berkshire Bank first reported a position in BMY in Q3 2020 and held it in 23 quarters. The position peaked at $3.51M in Q2 2021. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Berkshire Bank reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Berkshire Bank sold 4,026 Bristol-Myers Squibb shares in Q2 2026, an estimated $244K.
  • Berkshire Bank first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 23 quarters.
  • Berkshire Bank's Bristol-Myers Squibb position peaked at $3.51M in Q2 2021.
  • 832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Berkshire Bank's 13F filing for Q2 2026, filed 8 Jul 2026.